ServareGMP

ServareGMP is a new, non-profit public benefit corporation dedicated to developing and manufacturing low-cost biologic medicines against infectious diseases, unmet needs and neglected diseases affecting the most vulnerable populations. ServareGMP was established to help change this reality through three primary pathways: develop and manufacture very low-cost medicines; utilize its expertise and operations to partner with other like-minded organizations on their efforts to bring forth medicines aimed at underserved populations; collaborate with colleagues in LMICs to launch biomanufacturing operations in those locales

Servaregmp operates in the Biotechnology research industry.

Servaregmp's revenue is 11m - 100m

Servaregmp has 11 - 50 employees.